Ten-Year Clinical Outcome of recent-onset Axial Spondyloarthritis: results from the DESIR inception Cohort

Un nouvel article scientifique intitulé «Ten-Year Clinical Outcome of recent-onset Axial Spondyloarthritis: results from the DESIR inception Cohort» a été publié dans le journal Joint Bone Spine.

Dougados M, Serrand C, Alonso S, Berenbaum F, Claudepierre P, Combe B, Gossec L, Witrand AR, Saraux A, Wendling D, Querré TL, Molto A.


This study aimed to evaluate the 10-year clinical outcome of patients with recent-onset axial spondyloarthritis (axSpA).


Study design: The DESIR cohort is an inception cohort of axSpA patients.

Diagnosis and management:

The diagnosis and management of patients were based on the decision of the treating rheumatologist.

Statistical analysis:

Both complete cases and imputed data analyses were conducted.


Of the 708 enrolled patients, 45 were excluded due to a change in the baseline diagnosis, 3 patients died, and 300 were lost to follow-up over the 10y. In the completer population, one patient required bilateral total hip replacement, and 56 patients received a pension due to invalidity. The prevalence of main extra-musculoskeletal features increased from baseline to year 10: psoriasis from 18% to 30%, acute anterior uveitis from 10% to 18%, and inflammatory bowel disease from 5% to 10%. The most frequent comorbidity was hypertension, with an increase from 5% to 15% from baseline to year 10. In the imputed data analysis the estimated proportions of patients with an acceptable status at year 10 were 70% [95% CI: 63; 77] for acceptable PASS, 43% [95% CI: 37; 49] for BASDAI < 3, and 48% [95% CI: 41; 56] for ASDAS < 2.1.


These findings suggest that despite a quite favorable 10-year outcome exists for severe outcomes, a large proportion of patients present with an important disease burden reflected by patient-reported outcomes. This information can be valuable for providing patients with information at the time of diagnosis.

Keywords: cohort; long-term prognosis; spondyloarthritis.

Poster un commentaire